OMNIX MEDICAL LTD has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ADVANCED IMMUNI T INC, BIOTECON THERAPEUTICS GMBH and POLONELLI LUCIANO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Climate change adaptation technologies | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bachnoff Niv | 12 |
#2 | Cohen-Kutner Moshe | 11 |
#3 | Cohen Kutner Moshe | 1 |
Publication | Filing date | Title |
---|---|---|
US2020399329A1 | Antimicrobial peptides | |
US2019177379A1 | Combination of antimicrobial peptides and antibiotic drugs for treating diseases | |
CA2975971A1 | Antimicrobial peptides |